Supported by

TAVI (Transcatheter aortic valve implantation)

Find all the latest content on TAVI published on this website.

TAVI, now an established, valid treatment for patients presenting with symptomatic severe aortic stenosis, has proven to be superior to medical treatment for inoperable patients whilst being a valid alternative to surgery in select, high-risk patients. This topic covers the newest devices and emerging data in TAVI as well as information on tools, devices and techniques such as vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography, understanding bleeding risks or patient selection. Use the filters below to access PCRonline resources.

Anatomy of the aortic valvar complex

View a detailed and comprehensive description of the anatomy of the aortic valvar complex as it pertains to TAVI.

View illustrated aortic valvar complex

Filtered By
TAVI

1602 results

Cases in Japanese - PCI, MR & TAVI

16 Feb 2020 – From PCR Tokyo Valves 2020

Consult this session to discover various challenging cases, such as: PCI for coronary ischemia after EvolutR implantation, degenerative mitral regurgitation with large gap, bailout of ventricular septal defect after TAVI, and more!

Cases in Japanese - PCI, MR & TAVI

How should aortic stenosis be treated in the modern era and what is the role of the heart team?

15 Feb 2020 – From PCR Tokyo Valves 2020

Consult this session to gain insight into the current status of aortic stenosis treatment around the world, to learn more about the patient and treatment selection by the Heart Team, and to discover how the patient pathway's optimization may facilitate the increasing demand for TAVR.

How should aortic stenosis be treated in the modern era and what is the role of the heart team?

How to optimise coronary intervention therapy with SAPIEN 3

15 Feb 2020 – From PCR Tokyo Valves 2020

Consult this session to learn through various challenging cases about the optimal timing for performing coronary intervention for TAVI patients, the coronary access techniques for SAPIEN 3 patients and the differences in coronary access between balloon- and self-expandable devices.

How to optimise coronary intervention therapy with SAPIEN 3

Antithrombotic therapy for AF in bioprosthetic valve

15 Feb 2020 – From PCR Tokyo Valves 2020

Consult this session to learn more about the anticoagulant therapy for bioprosthetic valves with AF, the optimal stroke prevention strategy after TAVI and the clinical impact of the current data on leaflet thrombosis.

Antithrombotic therapy for AF in bioprosthetic valve

Valve selection for patients with longer life

15 Feb 2020 – From PCR Tokyo Valves 2020

Consult this session to learn more about patients with failed surgical bioprosthesis valves' treatment, valve selection impacts clinical and procedural outcomes, and discover some future trends in treating TAVI patients with longer life expectancy which may revolutionize your practice.

Valve selection for patients with longer life

Sizes, wires, and other innovations in TAVI technique and technology

15 Feb 2020 – From PCR Tokyo Valves 2020

Consult this session on innovations in TAVI technique and technology to learn more about new self-expanding TAVR valve sizes and TAVR wires, emerging developments in self-expandable TAVR implant best practices, and discover how to utilize these new technologies and techniques to achieve the best possible outcomes for AS patients.

Sizes, wires, and other innovations in TAVI technique and technology

TAVI and others

15 Feb 2020 – From PCR Tokyo Valves 2020

Consult this session to learn more about a study comparing the treatment's results of patients with bicuspid (BAV) and tricuspid aortic valve (TAV), in whom TAVI was performed, in terms of device success, early safety and clinical efficacy.

TAVI and others

Remaining limitation of TAVI

15 Feb 2020 – From PCR Tokyo Valves 2020

Consult this session to learn more about the remaining limitation of TAVI, such as conduction abnormalities, coronary access, severe aortic valve calcification, thanks to a selection of various interesting cases. 

Remaining limitation of TAVI

TAVI basics Co-Medicals - in Japanese

15 Feb 2020 – From PCR Tokyo Valves 2020

Consult this session in japanese to learn more about the roles of co-medicals (before and after procedure), the decision-making and strategies prior to TAVI, and the management of comorbidities post TAVI.

TAVI basics Co-Medicals - in Japanese

My best and worst cases of vascular access

15 Feb 2020 – From PCR Tokyo Valves 2020

Consult this session to learn thanks to a selection of challenging transcatheter aortic valve implantation cases how to analyse the access sites required, how to manage difficult access and complications, and discover some new approaches. 

My best and worst cases of vascular access

Aortic Valve Thrombosis

15 Feb 2020 – From PCR Tokyo Valves 2020

Consult this session on aortic valve thrombosis to learn how to manage the patients with a bioprosthetic valve at high risk of thrombosis and bleeding, and the key role of imaging (echo and CT) in these situations.

Aortic Valve Thrombosis

Challenging cases on mitral interventions, TAVI and LAA closure

15 Feb 2020 – From PCR Tokyo Valves 2020

Consult this session to discover various challenging cases, such as: systolic anterior motion with mitral regurgitation triggered by TAVI, transcatheter mitral valve repair using MitraClip through atrial septal defect, ACS complicating transcaval TAVI, and more!

Morning cases

Abstracts in Japanese

15 Feb 2020 – From PCR Tokyo Valves 2020

Consult this session to discover a selection of abstracts submitted during PCR Tokyo Valves 2020, such as: impact of beta blockers on patients undergoing TAVR, predictive factors of no symptomatic improvement after TAVI, and more!

Abstracts in Japanese

Challenging cases

15 Feb 2020 – From PCR Tokyo Valves 2020

Consult this session to discover challenging TAVI cases and high-risk procedures, regarding pulmonic valve stenosis and PPM, calcific aortic stenosis, degenerative aortic stenosis, and more. Watch it now to discover the chosen treatment!

Challenging cases

Complication cases

15 Feb 2020 – From PCR Tokyo Valves 2020

Consult this session to learn through a selection of complications cases how to manage transcatheter aortic valve migration, aorto-right ventricular fistula after TAVI, and sudden haemodynamic collapse during TAVI.

Complication cases

Session for the Co-medicals in Japanese

15 Feb 2020 – From PCR Tokyo Valves 2020

Consult this session dedicated to the co-medicals, to discover the nurse's perspective on percutaneous LAA closure, a study on the reduction of scattered radiation exposure in TAVI, and more!

Session for the Co-medicals in Japanese

Imaging Day - Case-based echo imaging for the aortic valve

14 Feb 2020 – From PCR Tokyo Valves 2020

Consult this session to learn more about low-flow low-gradient aortic stenosis, and discover how to predict prothesis-patient mismatch and how to detect prosthetic valve thrombosis.

Imaging Day - Case-based echo imaging for the aortic valve

PCR and TCT announce the creation of a New Educational Program: Partners in Learning

21 Jan 2020

New York, NY – Tuesday 21, 2020 – PCR and TCT are proud to announce the creation of a new educational program: “Partners in Learning”. The first of its kind will focus on TAVI practitioners, taking place on 21-22 March 2020 in Sao Paulo, Brazil. It...

PCR and TCT announce the creation of a New Educational Program: Partners in Learning

Best of PCRonline in 2019

13 Jan 2020

Thank you to the thousands of cardiologists and healthcare professionals whose contribution to the website provides the community with a valuable, free resource of education in cardiovascular interventions - this embodies the By and For that sets PCRonline apart! Thanks to you, over half a million...

Best of PCRonline in 2019

My five top trials in interventional cardiology in 2019: impact on clinical practice?

02 Jan 2020 – From GulfPCR-GIM 2020

Consult this session to learn all about the latest evidence from trials relevant for interventional cardiology, selected by EAPCI President Andreas Baumbach, and discover their impact on your daily practice: COMPLETE, BIOSTEMI, EXCEL, and more!

My five top trials in interventional cardiology in 2019 and their impact on clinical practice